VF
UTHR icon

VitalStone Financial’s United Therapeutics UTHR Stock Holding History

VitalStone Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.23K Buy
+9
New +$3.04K ﹤0.01% 340
2024
Q2 		– Sell
-44
Closed -$10K – 590
2024
Q1 		$10K Buy
+44
New +$9.93K 0.01% 279

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VitalStone Financial's UTHR Position: Q3 2024 in Review

VitalStone Financial opened a new position in United Therapeutics (UTHR) in Q3 2024: 9 shares worth $3.23K. The stake represents ﹤0.01% of the portfolio and ranks #340 among its holdings. This is a return to the name: VitalStone Financial previously reported a position in UTHR as recently as Q1 2024.

VitalStone Financial first reported a position in UTHR in Q1 2024 and has held it in 2 quarters since. The position peaked at $10K in Q1 2024. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • VitalStone Financial held 9 shares of United Therapeutics worth $3.23K as of Q3 2024.
  • United Therapeutics was a new VitalStone Financial position in Q3 2024.
  • United Therapeutics made up ﹤0.01% of VitalStone Financial's portfolio in Q3 2024, its #340 holding.
  • VitalStone Financial first reported a position in United Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • VitalStone Financial's United Therapeutics position peaked at $10K in Q1 2024.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.